Madrigal pharmaceuticals appoints shannon kelley as general counsel

Conshohocken, pa., aug. 02, 2024 (globe newswire) -- madrigal pharmaceuticals, inc. (nasdaq:mdgl), a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (nash), today announced the appointment of shannon kelley as general counsel, effective august 5, 2024.
MDGL Ratings Summary
MDGL Quant Ranking